// App-Quantinova.ai

: A Novel Ex Vivo Normothermic Perfusion Model of Human Antibody Mediated Rejection

Researchers

Presenter

  • P. Chandak

Principal Investigators

  • B. L. Phillips

  • R. Uwechue

  • C. J. Callaghan

  • O. Shaw

  • T. Maggs

  • L. Woodford

  • D. Veniard

  • R. Perera

  • K. Parmar

  • B. Hunt

  • D. Bennett

  • N. Kessaris

  • A. Dorling

  • N. Mamode

Medical Centers

  • Transplantation, Guy's and St Thomas Hospitals NHS Trust and King's College London, London, United Kingdom

  • Transplantation, Guy's and St Thomas Hospitals NHS Trust and King's College London, London, United Kingdom

  • Haematology and Thrombosis, Guy's and St Thomas Hospitals NHS Trust, London, United Kingdom

  • Histopathology, Guys and St Thomas Hospitals NHS Foundation Trust, London, United Kingdom

  • Haematology and Thrombosis, Guy's and St Thomas Hospitals NHS Trust, London, United Kingdom

  • Interface Physics, University of Bristol, London, United Kingdom

  • Inflammation, Thrombosis and Repair and Transplantation, Guy's and St Thomas Hospitals NHS Trust and King's College London, London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Autoimmune (AI)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Chronic antibody mediated rejection

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved